Publications To Date


    Filter Publications

    PAGE 2 OF 11 | DISPLAYING 16 - 30 OF 160 RESULTS

    Sugio T. et. al., Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS, 10.1182/bloodadvances.2018018754, Blood Adv., Sep 07, 2018

    Moyes K.W. et. al., Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma., 10.1080/2162402X.2018.1507668., Oncoimmunology, Aug 27, 2018

    Jiang P. et. al., Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response,, Nature Med., Aug 20, 2018

    Chakravarthy A. et. al., Pan-cancer deconvolution of tumour composition using DNA methylation,, Nature Commun., Aug 13, 2018

    Kim S-S. et. al., Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor, 10.1080/2162402X.2018.1484982, Oncoimmunology, Aug 01, 2018

    Polumuri S.K. et. al., Aggregates of IVIG or Avastin, but not HSA, modify the response to model innate immune response modulating impurities,, Sci. Reports, Jul 31, 2018

    Owens G.L. et. al., Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells, 10.1007/s00262-018-2211-3, Cancer Immunol. Immunother., Jul 23, 2018

    Pollari M. et. al., PD-L1+ tumor-associated macrophages and PD-1+ tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma, 10.3324/haematol.2018.197194, Haematalogica, Jul 19, 2018

    Nguyen A. et. al., HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants,, Cell Reports, Jul 17, 2018

    Oseledchyk A. et. al., Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus, 10.18632/oncotarget.25614, Oncotarget, Jun 19, 2018

    Chihara N. et. al., Induction and transcriptional regulation of the co-inhibitory gene module in T cells,, Nature, Jun 13, 2018

    Yeong Y. et. al., 2018 High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer, , Frontiers in Immunol., May 30, 2018

    Chen M. et. al., 2018 JAK2 and PD-L1 amplification enhance the dynamic expression of PD-L1 in triple negative breast cancer,, Clin. Breast Can., May 26, 2018

    Gullo I. et. al., 2018 New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression., 10.1007/s10120-018-0836-8, Gastric Cancer, May 19, 2018

    Ignatiadis M. et. al., 2018 Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy., 10.1093/jnci/djy076., JNCI, May 18, 2018